Innovis Asset Management »

Revance Therapeutics shares owned by Innovis Asset Management

Quarter-by-quarter ownership of Revance Therapeutics (RVNC) shares owned by Innovis Asset Management from 13F filings

Historical chart of Innovis Asset Management investment in Revance Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Revance Therapeutics held by Innovis Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Revance Therapeutics by Innovis Asset Management

Quarter filed Position value Share count Share price at filing
2023-09-30 $442k 39k 11.47
2023-06-30 $266k 11k 25.31